Articles with public access mandates - Afzal A. SiddiquiLearn more
Not available anywhere: 4
Sm‐p80‐based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re‐encounter
AJ Siddiqui, AJ Molehin, W Zhang, PK Ganapathy, E Kim, JU Rojo, ...
Annals of the New York Academy of Sciences 1425 (1), 19-37, 2018
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in …
L Le, W Zhang, S Karmakar, G Ahmad, W Torben, AA Siddiqui
Parasitology research 113, 1195-1200, 2014
Mandates: US National Institutes of Health
Testing of Schistosoma mansoni Vaccine Targets
W Zhang, A Molehin, P Patel, E Kim, A Peña, AA Siddiqui
Schistosoma mansoni: Methods and Protocols, 229-262, 2020
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Translational Activities to Enable NTD Vaccines
SA Gray, RN Coler, D Carter, AA Siddiqui
Progress in Molecular Biology and Translational Science 142, 291-315, 2016
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Available somewhere: 34
Schistosomiasis vaccines
AA Siddiqui, BA Siddiqui, L Ganley-Leal
Human vaccines 7 (11), 1192-1197, 2011
Mandates: US National Institutes of Health
Preclinical Prophylactic Efficacy Testing of Sm-p80–Based Vaccine in a Nonhuman Primate Model of Schistosoma mansoni Infection and Immunoglobulin G and E …
G Ahmad, W Zhang, W Torben, A Ahrorov, RT Damian, RF Wolf, GL White, ...
Journal of Infectious Diseases 204 (9), 1437-1449, 2011
Mandates: US National Institutes of Health
Sm-p80-based schistosomiasis vaccine: preparation for human clinical trials
AA Siddiqui, SZ Siddiqui
Trends in parasitology 33 (3), 194-201, 2017
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Development of a schistosomiasis vaccine
AJ Molehin, JU Rojo, SZ Siddiqui, SA Gray, D Carter, AA Siddiqui
Expert review of vaccines 15 (5), 619-627, 2016
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model
G Ahmad, W Zhang, W Torben, RT Damian, RF Wolf, GL White, ...
Vaccine 27 (21), 2830-2837, 2009
Mandates: US National Institutes of Health
Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously …
G Ahmad, W Zhang, W Torben, C Haskins, S Diggs, Z Noor, L Le, ...
Parasitology research 105, 1767-1777, 2009
Mandates: US National Institutes of Health
Sm‐p80‐based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni
G Ahmad, W Torben, W Zhang, M Wyatt, AA Siddiqui
Parasite immunology 31 (3), 156-161, 2009
Mandates: US National Institutes of Health
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons
S Karmakar, W Zhang, G Ahmad, W Torben, MU Alam, L Le, RT Damian, ...
Vaccine 32 (11), 1296-1303, 2014
Mandates: US National Institutes of Health
Experimental vaccines in animal models for schistosomiasis
AA Siddiqui, G Ahmad, RT Damian, RC Kennedy
Parasitology research 102, 825-833, 2008
Mandates: US National Institutes of Health
Sm‐p80‐based schistosomiasis vaccine: double‐blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission‐blocking efficacy
W Zhang, AJ Molehin, JU Rojo, J Sudduth, PK Ganapathy, E Kim, ...
Annals of the New York Academy of Sciences 1425 (1), 38-51, 2018
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Sm-p80—Based DNA Vaccine Provides Baboons with Levels of Protection against Schistosoma mansoni Infection Comparable to Those Achieved by the …
W Zhang, G Ahmad, W Torben, Z Noor, L Le, RT Damian, RF Wolf, ...
The Journal of infectious diseases 201 (7), 1105-1112, 2010
Mandates: US National Institutes of Health
Use of an Sm-p80–Based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons
S Karmakar, W Zhang, G Ahmad, W Torben, MU Alam, L Le, RT Damian, ...
The Journal of infectious diseases 209 (12), 1929-1940, 2014
Mandates: US National Institutes of Health
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice
G Ahmad, W Zhang, W Torben, Z Noor, AA Siddiqui
International Journal of Infectious Diseases 14 (9), e781-e787, 2010
Mandates: US National Institutes of Health
Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models
W Torben, G Ahmad, W Zhang, AA Siddiqui
Vaccine 29 (12), 2262-2271, 2011
Mandates: US National Institutes of Health
Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni
W Torben, G Ahmad, W Zhang, S Nash, L Le, S Karmakar, AA Siddiqui
Vaccine 30 (48), 6753-6758, 2012
Mandates: US National Institutes of Health
Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon
W Zhang, G Ahmad, L Le, JU Rojo, S Karmakar, KA Tillery, W Torben, ...
Parasitology research 113, 2239-2250, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program